Skip to main content
. 2004 Oct 12;91(9):1687–1693. doi: 10.1038/sj.bjc.6602156

Table 1. Associations of ER-α, ER-β and SRC-1 with clinicopathological parameters, comparisons with Fishers exact test.

  Total ER-α positivity (%) P-value ER-β positivity (%) P-value SRC-1 positivity (%) P-value
No. of patients 150 123 (82%) 87 (58%) 28 (19%)
Patient age (years)              
 ⩽50 69 56 (81%)   35 (51%)   21 (30%)  
 >50 81 67 (83%) 0.8338 52 (64%) 0.1009 7 (9%) 0.0007
               
Tumour size (mm)              
 ⩽35 107 85 (79%)   67 (63%)   9 (8%)  
 >35 43 38 (88%) 0.2448 20 (47%) 0.0991 19 (44%) <0.0001
               
Histological grade              
 Grade 3 74 64 (86%)   46 (62%)   17 (23%)  
 Non-Grade 3 76 59 (78%) 0.2030 41 (54%) 0.3256 11 (14%) 0.2120
               
Node status              
 Node positive 94 78 (83%)   53 (56%)   20 (21%)  
 Node negative 56 45 (80%) 0.8264 34 (61%) 0.6133 8 (14%) 0.3869
               
HER-2-neu expression              
 Her-2-neu positivity 38 34 (89%)   10 (26%)   16 (42%)  
 Her-2-neu negativity 112 89 (79%) 0.2234 77 (69%) <0.0001 12 (11%) <0.0001
               
SRC-1 expression              
 SRC-1 positivity 28 25 (89%)   7 (25%)  
 SRC-1 negativity 122 98 (80%) 0.4130 80 (66%) 0.0001  
               
Recurrences              
 Recurrence 29 26 (90%)   7 (24%)   26 (90%)  
 Nonrecurrence 121 97 (80%) 0.2911 80 (66%) <0.0001 2 (2%) <.0001
HHS Vulnerability Disclosure